Financials

  • Market Capitalization 8.43 B
  • Employee 691
  • Founded 2014
  • CEO Rich Adcock
  • Website www.immunitybio.com
  • Headquarter Delaware, United States
  • FIGI BBG007T9DYW9
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-9.03
市销率
52.32

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
992
ABVX
Abivax SA - American Depositary Shares
111.73 USD-1.43%-5.31%-7.20%+39.65%8.77 B USD
1018
APGE
Apogee Therapeutics, Inc. - Common Stock
135.08 USD+0.08%+0.17%+0.72%+152.06%8.40 B USD
1025
IMVT
Immunovant, Inc. - Common Stock
40.79 USD-1.00%-5.84%+6.56%+112.34%8.43 B USD
1039
TGTX
TG Therapeutics, Inc. - Common Stock
54.30 USD+0.69%-3.05%+7.12%+84.88%8.31 B USD

新闻